Yisheng Pharmaceutical (002566.SZ) released its performance for the first three quarters, with net profit attributable to the parent company of 21.24 million yuan, a year-on-year decrease of 11.97%.

Zhitong Finance APP News, Yisheng Pharmaceutical (002566.SZ) released its 2026 third-quarter report. In the first three quarters, the company achieved operating revenue of 435 million yuan, a year-on-year decrease of 8.58%; net profit attributable to shareholders of the listed company was 21.24 million yuan, a year-on-year decrease of 11.97%; net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 11.7433 million yuan, a year-on-year decrease of 6.51%; basic earnings per share were 0.0642 yuan.